Application no. and date | 15722195.3 (espacenet) (Federated) (European Patent Register), 20150512 | Patent/reg. no. and date | DK/EP 3142751, 20190807 | Publication date | 20170322 | Priority no. and date | US 201461992658 P, 20140513, US 201562105992 P, 20150121, US 201562114336 P, 20150210 | EP pub. no. and date |
EP 3142751 20170322 | Effective date | | Applicant/owner | MedImmune Limited, Milstein Building Granta Park
Cambridge Cambridgeshire CB21 6GH, GB | Applicant ref. no. | 1513740 | Inventor | NARWAL, Rajesh, c/o MedImmune LLC One MedImmune Way
Gaithersburg Maryland 20878, US, ROBBINS, Paul, c/o MedImmune LLC One MedImmune Way
Gaithersburg Maryland 20878, US, KARAKUNNEL, Joyson, c/o MedImmune LLC One MedImmune Way
Gaithersburg Maryland 20878, US, DAR, Mohammed M., c/o MedImmune LLC One MedImmune Way
Gaithersburg Maryland 20878, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | Anti-B7-H1- og anti-CTLA-4-antistoffer til behandling af ikke-småcellet lungecancer | Int. application no. | EP2015060523 | Int. publication no. | WO2015173267 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|